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SUMMARY 17 
The interaction of KstR2-dependent promoters of the divergon constituted by the 18 
MSMEG_6000-5999 and MSMEG_6001-6004 operons of Mycobacterium smegmatis 19 
which encode the genes involved in the lower cholesterol degradative pathway has been 20 
characterized. Footprint analyses have demonstrated experimentally for the first time 21 
that KstR2 specifically binds to an operator region of 29 nucleotides containing the 22 
palindromic sequence AAGCAAGNNCTTGCTT. This region overlaps with the -10 and 23 
-35 boxes of the putative P6000 and P6001 divergent promoters, suggesting that KstR2 24 
represses their transcription by preventing the binding of the RNA polymerase. A 3D-25 
model of the KstR2 protein revealed a typical TetR-type regulator folding with two 26 
domains, a DNA-binding N-terminal domain and a regulator-binding C-terminal 27 
domain composed by 3 and 6 helices, respectively. KstR2 is an all α protein as confirmed 28 
by circular dichroism. We have determined that M. smegmatis is able to grow using 29 
sitolactone (HIL) as the only carbon source and that this compound induces the kstR2 30 
regulon in vivo. HIL or its open form 5OH-HIP were unable to release in vitro the 31 
KstR2-DNA operator interaction, suggesting that 5OH-HIP-CoA or a further derivative 32 
would induce the lower cholesterol catabolic pathway. 33 
 34 
Introduction 35 
Several species of Mycobacteria, including Mycobacterium tuberculosis, are able to grow on 36 
cholesterol as the sole carbon and energy source (García et al., 2012). Recent studies have 37 
demonstrated that cholesterol plays a fundamental role in tuberculosis infection which has 38 
promoted an intensive study of mycobacterial cholesterol catabolism during the last years in 39 
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this bacterium (Sassetti and Rubin, 2003; Schnappinger et al., 2003; Rengarajan et al., 2005; 40 
Brzostek et al., 2007; Chang et al., 2007; Pandey and Sassetti, 2008; Yam et al., 2009; Hu et 41 
al., 2010; Nesbitt et al., 2010). Different biochemical and genetic studies have assigned a 42 
function to many mycobacterial genes involved in cholesterol catabolism (Knol et al., 2008; 43 
Capyk et al., 2009; Lack et al., 2009; Yam et al., 2009), but numerous issues concerning the 44 
degradative pathway and its regulation still remain to be fully elucidated. 45 
Cholesterol utilization in mycobacteria is controlled by at least two TetR-type transcriptional 46 
repressors named KstR and KstR2 (Kendall et al., 2007, 2010; Uhía et al., 2011a). KstR 47 
controls the expression of 83 catabolic genes (kstR regulon) (Kendall et al., 2007) whereas 48 
KstR2 controls the expression of 15 genes distributed in 5 operons involved in the lower 49 
catabolic pathway (Kendall et al., 2010). The inducer of KstR in M. smegmatis is 3-oxo-4-50 
cholestenoic acid (García-Fernández et al., 2014) whereas KstR2 is induced by 3aα-H-4α(3′-51 
propanoyl-CoA)-7aβ-methylhexahydro-1,5-indanedione (HIP-CoA) (Casabon et al., 2013). 52 
KstR binds as a dimer to DNA probes containing the motif (TNNAACNNGTTNNA) 53 
(Kendall et al., 2007; Uhía et al., 2011a) whereas KstR2 has been postulated to bind as a 54 
dimer to the motif (ANCAAGNNCTTGNT) (Kendall et al., 2010). Nevertheless, 55 
experimental evidence that this motif represents the authentic KstR2 operator remains to be 56 
presented.  57 
To provide further insights into the role of KstR2 in the regulation of the lower pathway of 58 
cholesterol catabolism, we have studied the interaction of this repressor with the promoters of 59 
the divergon constituted by the MSMEG_6000-5999 and MSMEG_6001-6004 operons of M. 60 
smegmatis which encode several genes of the lower cholesterol degradative pathway. 61 
Moreover, our finding that M. smegmatis is able to grow in sitolactone (HIL) opens some 62 
questions about the existence of alternative inducers of KstR2. 63 
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 64 
Results and discussion 65 
In silico analysis of the divergon constituted by the MSMEG_6000-5999 and MSMEG_6001-66 
6004 operons. 67 
The lower pathway of cholesterol catabolism is constituted by, at least, 15 genes 68 
belonging to the kstR2 regulon (Kendall et al., 2010). These genes are arranged in 5 putative 69 
transcriptional units where 4 of them appear to be organized as typical divergons (Beck and 70 
Warren, 1988; Bendtsen et al., 2011) (Fig. 1). 71 
To study the regulation mediated by KstR2 from M. smegmatis we selected the region 72 
containing the divergon constituted by the MSMEG_6000-5999 and MSMEG_6001-6004 73 
operons. The divergon containing these promoters, named hereafter P6000 and P6001, showed a 74 
putative KstR2 operator sequence (Fig. 1). Moreover, we had previously demonstrated that 75 
the genes expressed by this divergon were induced when M. smegmatis grew in cholesterol as 76 
the sole carbon and energy source (Uhía et al., 2011b). On the other hand, it is worth to 77 
mention that the putative MSMEG_6000-5999 and MSMEG_6001-6004 operons are 78 
homologous to the corresponding operons in M. tuberculosis and Rhodococcus jostii RHAI.  79 
The intergenic region of the divergon located between the two divergent 80 
MSMEG_6000-5999 and MSMEG_6001-6004 operons has only 60 bp (Fig. 1) and 81 
approximately in the middle of this region we have located the palindromic sequence 82 
AGCAAGTGCTTGCT that is similar to the consensus sequence postulated for the KstR2 83 
operator (Kendall et al., 2010). This palindromic sequence is located between the putative -10 84 
and -35 boxes of the divergent promoters (Fig. 1). 85 
Interaction of the divergon with the KstR2 regulator 86 
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The ability of KstR2 to bind to the divergon region was tested in vitro by gel retardation assay 87 
(EMSA) using the 6000FP DNA probe containing the divergon (164 bp) and increasing 88 
concentrations of purified KstR2 protein (Fig. S1a). KstR2 was able to retard the migration of 89 
the divergon region in a protein concentration dependent manner. Furthermore, the KstR2 90 
binding was highly specific since an excess of unlabelled MSMEG_6000FP probe added to 91 
the reaction mixture abolished the probe gel retardation, whereas the unrelated DNA from 92 
salmon sperm did not (Fig. S1b). 93 
Characterization of the KstR2 operator sequence 94 
To precisely localize the KstR2 operator at the divergon
 
a DNaseI footprinting analysis was 95 
performed using the 6000FP DNA probe and increasing concentrations of the KstR2 purified 96 
protein (Fig. 2). The result revealed that KstR2 protects a region of 26-29 nucleotides, located 97 
only 11 nucleotides upstream of the translation start codon of the MSMEG_6000 gene. This 98 
region contains the sequence AAGCAAGCACTTGCTT, i.e., an extended palindromic 99 
sequence when compared to the previously postulated AnCAAGnnCTTGnT operator 100 
sequence (Kendall et al., 2010). 101 
Taking into account that this palindrome overlaps with the putative -10 and -35 boxes 102 
of both promoters of the divergon we suggest that most probably the binding of KstR2 to this 103 
operator region prevents the binding of RNA polymerase in both cases. 104 
Homology modelling of KstR2 105 
As stated above, KstR2 belongs to the TetR family of transcriptional regulators that includes 106 
more than 2000 non-redundant sequences (Ramos et al., 2005). As we did in the case of KstR 107 
(Uhía et al., 2011a), using the PROSITE database, we have identified the typical DNA-108 
binding helix-turn-helix (HTH) domain characteristic of the TetR-type regulators (Orth et al., 109 
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2000). This domain is formed by the three helices of the N-terminal domain (H1-H3) and the 110 
beginning of the first helix (H4) of the C-terminal domain. The C-terminal domain showed 111 
low sequence similarity with other TetR-type regulators limiting the possibility of speculating 112 
about the possible inducer molecule. Nevertheless, due to the similarity to other TetR-type 113 
regulators we were able to carry out a three-dimensional structure modelling of KstR2. 114 
The most similar structure deposited in the PDB was selected using the HHpred 115 
program that utilizes sequence alignment and secondary structure prediction to look for 116 
similarities (Söding, 2005). The PDB entry that showed most similarity to KstR2 was 2IBD 117 
that corresponds to a putative TetR-type regulator from Rhodococcus jostii RHA1. The model 118 
(Fig. S2a) obtained using the Geno3D program (Combet et al., 2002) shows a typical TetR-119 
type regulator folding with two domains. The DNA-binding N-terminal domain and the 120 
regulator-binding C-terminal domain composed of six helices with a long tunnel-shaped 121 
hydrophobic pocket formed, in part, by residues from these helices (F66, L67, L70, F71 and 122 
Y74 from helix H4; L88, L91, S85 and A98 from helix H5; Y109 from helix H6; Q132, 123 
W136 and I139 from helix H7; V158, I162, T166 and W167 from helix H8; and Y188 and 124 
V192 from helix H9 showed as sticks in Fig. S2a). All of these residues, but three, are 125 
hydrophobic indicating a high probability for the binding of hydrophobic inducers. 126 
The α-helix content of the KstR2 model is 81.5%. To confirm this secondary structure 127 
content we have estimated it by circular dichroism (Fig. S2b). The estimated content in α-128 
helix of the protein without bonded DNA is around 52%. This content is lower than that of the 129 
model, but as it has been seen in crystal structures of unliganded TetR-type regulators most of 130 
the N-terminal domain and a small part of the C-terminal domain does not present a defined 131 
structure and cannot be seen in some of these structures (Hernández et al., 2009, Hernández et 132 
al., 2011), lowering the secondary structure content of the non-bonded forms of these type of 133 
7 
 
regulators. Moreover, this result resembles the finding that the α-helical content of the 134 
crystallographic structure of KstR is 84% (PDB ID 3MNL) whereas the CD analysis renders a 135 
protein with 62 % of α-helical content (García-Fernández et al., 2014). 136 
Analysis of the KstR2 inducer 137 
Sitolactone (HIL) is the only catabolic intermediate of the lower pathway that is commercially 138 
available so far. This compound is industrially produced by fermentation of phytoesterols 139 
with a mutant of Nocardia corallina that secretes 5OH-HIP to the culture medium 140 
(Nakamatsu et al., 1982). 141 
As mentioned above, Casabon et al. (2013) have proposed that HIP-CoA is the true 142 
inducer of KstR2. Therefore, according to this proposal the next intermediate of the pathway 143 
should be 5-OH-HIP-CoA (Fig. 3). When the lower pathway is blocked, like in N. coralline, 144 
5-OH-HIP-CoA is hydrolyzed to 5OH-HIP and secreted to be further transformed into HIL 145 
(silotactone) by acidification. Taking into account this hypothesis, HIL or 5OH-HIP could not 146 
be used as a unique carbon source by M. smegmatis because even in the case that they could 147 
be transformed into 5-OH-HIP-CoA to enter the pathway, this compound could not induce 148 
KstR2. However, before the publication of the results of Casabon et al. (2013) we had 149 
observed that HIL can be used as sole carbon an energy source by M. smegmatis. In addition, 150 
both the wild type M. smegmatis and the KstR2 constitutive mutant (∆Kstr2) grow at the same 151 
rate in HIL, cholesterol and in co-feeding experiments using HIL (4 mM) and a small amount 152 
of glycerol (1 mM) as co-substrate (Fig. S3), suggesting that HIL is able to induce efficiently 153 
KstR2. 154 
In fact, we determined that in the presence of HIL the genes of the kstR2 regulon are 155 
induced whereas the genes of the kstR regulon remain expressed at their basal levels (Fig. 4) 156 
Moreover, we have determined that the kstR2 regulon is not constitutively activated after 157 
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growing the cells in a HIL containing medium, discarding the possibility that we could have 158 
isolated a KstR2 mutant after growing the cells in HIL.  159 
These results demonstrate not only that HIL and 5OH-HIP can be metabolized through 160 
the lower cholesterol catabolic pathway but also that they can induce the kstR2 regulon. One 161 
possibility to explain this behavior is that 5OH-HIP could be transformed into HIP by a 162 
dehydrogenase before entering the pathway. Nevertheless, this reaction has not been 163 
described so far and appears to be very improbable. Another possibility could be that 5OH-164 
HIP could enter the pathway after being transformed into 5OH-HIP-CoA. In fact, Casabon et 165 
al. (2013) have shown that the FadD3 ligase is also able to generate 5OH-HIP-CoA, although 166 
at a very low rate. Even more, van der Geize et al. (2011) have described that the IpdAB 167 
CoA-transferase from Rhodococcus can transform 5OH-HIP into 5OH-HIP-CoA. The A and 168 
B subunits of the Ipd CoA-transferase are encoded in M. smegmatis by the MSMEG_6002 and 169 
MSMEG_6003 genes, respectively (Fig. 1). Therefore, if this was the case, HIL, 5OH-HIP, 170 
5OH-HIP-CoA or a further CoA derivative should be able to induce KstR2 to open the 171 
pathway. In this sense, when we tested by EMSA the capacity of HIL or 5OH-HIP to release 172 
the KstR2-DNA interaction, we did not observe any effect even at high concentrations (data 173 
not shown). This result suggests that the inducer should be 5OH-HIP-CoA or a further CoA 174 
derivative, which unfortunately were not commercially available to be tested. Taking into 175 
account all these results together we propose that KstR2 should responds not only to HIP-176 
CoA as previously stated (Casabon et al., 2013) but alternatively to 5OH-HIP-CoA or to other 177 
CoA structurally related compounds that are produced in the pathway later on, rendering it 178 
more versatile to catabolize other metabolites. 179 
Conclusions 180 
9 
 
We have experimentally demonstrated for the first time that the KstR2 regulator binds to a 181 
specific operator in the promoter region of the MSMEG_6000 gene strongly supporting the 182 
previous in silico predictions. KstR2 specifically binds in this region to the palindromic 183 
sequence AAGCAAGCACTTGCTT. A short version of this palindromic sequence 184 
(AGCAAGNNCTTGCT) is located upstream of the other operons controlled by KstR2. This 185 
operator region overlaps with the -10 and -35 boxes of the P6000 promoter, suggesting that 186 
KstR2 prevents the binding of RNA polymerase and thus the initiation of transcription. The in 187 
silico analysis of the P6000 promoter suggests that the mRNA transcribed from this gene is a 188 
leaderless transcript, i.e., it lacks a 5’ untranslated region (5’UTR) and thus starts directly at 189 
the AUG start codon. This observation adds an additional complexity to the regulation of this 190 
gene, since the absence of a ribosome binding site (RBS) suggests that the efficient translation 191 
of this gene is partially impaired and, as occurs in other leaderless genes, it might depend on 192 
specific physiological circumstances. The microarray data indicate that under induction 193 
conditions the MSMEG_6000 gene is expressed about 3-10 fold more than the MSMEG_6001 194 
gene (Kendall et al., 2010; Uhía et al., 2012). Probably, the higher expression of 195 
MSMEG_6000 might compensate the absence of RBS. 196 
The observation that a single KstR2 binding sequence is located within the promoter 197 
regions of the divergons constituted by the MSMEG_6000-5999 and MSMEG_6001-6004 198 
operons and MSMEG_6012-6011 and MSMEG_6013-6017 operons suggests that the 199 
corresponding promoters of the divergent operons are controlled by a single KstR2 dimer. As 200 
mentioned above this kind of regulatory arrangement is not infrequent in bacteria (Beck and 201 
Warren, 1988; Bendtsen et al., 2011) and for instance, it is very similar to the regulatory 202 
arrangement described for the structural genes for tetA, the Tnl0 tetracycline-resistance 203 
function, and for tetR, the Tnl0 tet repressor, which are transcribed in opposite directions from 204 
promoters in a regulatory region located between the two structural genes (Bertrand et al., 205 
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1983). Expression of both tetA and tetR is induced by tetracycline. It is also the case of the 206 
fepA-fes promoters of E. coli that present a single regulatory binding site controlled by the 207 
iron uptake regulation (Fur) protein (Escolar et al., 1998). However, in our case it is not 208 
evident if the spatial distribution of regulatory elements within the DNA region allows the 209 
simultaneous binding of the RNA polymerase to both promoters and their coordinate 210 
regulation regardless of their different transcriptional activities. It has been proposed that 211 
steric hindrance could occur between RNA polymerase molecules attempting to bind 212 
simultaneously to the overlapping promoters, even if the major parts of the promoters lie on 213 
opposite sides of the double helix (Beck and Warren, 1988). Such competition between the 214 
promoters could reduce the activity of either one or both of them. In this event, inactivation of 215 
either promoter would be expected to increase the activity of the other. However, it has also 216 
been proposed that the regulation of a weak promoter can be efficiently achieved by 217 
overlapping with a strong promoter controlled by a single and common regulatory binding 218 
site, because in this case the regulatory switch appears to be directed by the RNAP with the 219 
greater affinity, thus overcoming the need for two independent binding sites to control both 220 
promoters (Escolar et al., 1998). In addition to the benefits associated with the fine tuning of 221 
gene expression (Beck and Warren, 1988), sharing a single regulatory binding site to control 222 
two divergent promoters might add a metabolic economic benefit to the cell since it reduces 223 
the cost of producing large amounts of regulator molecules required to control complex 224 
regulons with many promoters. 225 
Finally, our observation that HIL can be used as a sole carbon and energy source by 226 
M. smegmatis by inducing the kstR2 regulon opens new questions about the configuration of 227 
the lower cholesterol catabolic pathway and about the possible flexibility of KstR2 for 228 
accepting alternative related inducers to increase the catabolic versatility of the pathway. The 229 
ability to use sterols as the only carbon source is an unusual attribute that is known to be 230 
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shared by only a handful of environmental organisms. M. tuberculosis clearly inherited this 231 
capacity from its saprophytic ancestors (Peterson et al., 1961), a trait that was retained 232 
because it enabled the bacteria to acquire carbon and energy in an intracellular compartment 233 
that effectively starves other potential pathogens (Pandey and Sassetti, 2008). However, M. 234 
tuberculosis infecting human cells would have no access to natural steroids different from 235 
cholesterol or cholestenone, whereas M. smegmatis would find in the soil phytosterols and 236 
many other esters of steroids that could be used as substrates. For this reason cholesterol 237 
catabolism of M. smegmatis might be more flexible and accept a larger variety of substrates 238 
than the orthologous enzymes from M. tuberculosis. Moreover, the observation that the KstR2 239 
regulon can be activated in the absence of cholesterol strongly suggests that the lower 240 
pathway may act as a metabolic funnel to catabolise other compounds not channelled through 241 
the KstR regulon. This appears to be the case for the catabolism of cholesterol and cholate in 242 
Rhodococcus spp. (Mohn et al., 2012). 243 
 244 
Experimental procedures 245 
Bacterial strains, plasmids, and culture conditions 246 
Bacterial strains, plasmids and primers used in this study are listed in Table 1. Unless 247 
otherwise stated, Escherichia coli was grown in Luria-Bertani (LB) medium (Sambrook and 248 
Russell, 2001) at 37 °C and where appropriate, kanamycin (50 µg/ml) was added to the 249 
medium. M. smegmatis mc2155 was grown in Middlebrook 7H9 broth (Difco) containing 250 
10% albumin-dextrose-catalase (ADC) supplement (Becton Dickinson), 0.2% glycerol, and 251 
0.05% Tween80 or on 7H10 solid agar medium with the same supplements without Tween80. 252 
For growth in glycerol, cholesterol and sitolactone as sole carbon sources, 7H9 minimal 253 
medium (without supplements) was used, and the carbon sources were added at 18, 1.8, and 4 254 
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mM, respectively. Stocks of 5 mM cholesterol and 10 mM sitolactone (HIL, γ-lactone form of 255 
3aα-H-4α (3’-propionic acid)-5α-hydroxy-7aβ-methylhexahydro-1-indanone (5OH-HIP)) 256 
were dissolved in 10% of tyloxapol at 80 °C and then autoclaved. M. smegmatis was always 257 
grown at 37 °C in an orbital shaker at 250 rpm.  258 
DNA manipulations and sequencing 259 
DNA manipulations and other molecular biology techniques were essentially as described 260 
(Sambrook and Russell, 2001). Plasmid DNA was prepared with a High Pure plasmid 261 
isolation kit (Roche Applied Science). DNA fragments were purified with Gene-Clean Turbo 262 
(Q-BIOgene). Transformation of E. coli cells was carried out by electroporation (Gene Pulser; 263 
Bio-Rad) (Wirth et al., 1989). Oligonucleotides were synthesized on an Oligo-1000M 264 
nucleotide synthesizer (Beckman Instruments). All cloned inserts and DNA fragments were 265 
confirmed by DNA sequencing through an ABI Prism 377 automated DNA sequencer 266 
(Applied Biosystems Inc.). DNA amplification was performed on a Mastercycler Gradient 267 
(Eppendorf) using DNA polymerase I and Pfu polymerase from Biotools B. M. Labs. 268 
Reaction mixtures contained 1.5 mM MgCl2 and 0.25 mM dNTPs. The amplified products 269 
were purified with High Pure PCR System Product Purification Kit (Roche). 270 
For M. smegmatis genomic DNA extraction, 15 ml of an overnight culture were 271 
centrifuged; the pellet was resuspended in 400 µl of TE (Tris-EDTA; 10 mM Tris-HCl pH 7.5 272 
and 1 mM EDTA) and incubated 20 min at 80 ºC. After cooling at room temperature, 50 µl of 273 
lysozyme (10 mg/ml) were added and the mixture was incubated 1 h at 37 ºC. 75 µl of 10% 274 
SDS containing proteinase K (10 mg/ml) were added before incubation for 10 min at 65 ºC. 275 
100 µl of 5 M NaCl and 100 µl of CTAB/NaCl preheated at 65 ºC were added followed by 10 276 
min incubation at 65 ºC. 750 µl of chloroform/isoamilic alcohol (24:1) were added, the 277 
mixture was vortexed and centrifuged 5 min at 14000 x g. The aqueous phase was transferred 278 
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to a new tube and an equal volume of phenol/chloroform/isoamilic alcohol (25:24:1) was 279 
added. The mixture was vortexed and centrifuged 5 min at 14000 x g. The aqueous phase was 280 
transferred to a new tube and the DNA was precipitated with a 0.6 volume of isopropanol. 281 
The DNA was centrifuged 15 min at 14000 x g at 4º C, washed with 70% ethanol, centrifuged 282 
2 min at 14000 x g and air-dried or dried using a miVac DNA concentrator (GeneVac Inc). 283 
Finally, the DNA was resuspended in 40-100 µl of TE. 284 
RNA extraction 285 
RNA for real time quantitative PCR was extracted from 25 ml of cultured M. smegmatis 286 
mc2155 growing in 1.8 mM cholesterol, 18 mM glycerol, or 4 mM sitolactone (HIL) as 287 
described previously (Uhía et al., 2011). RNA was treated with DNase I and removal 288 
treatment kit (Ambion) according to the manufacturer’s instructions. RNA quantity was 289 
measured using a Nano Photometer Pearl (Implen). Reverse transcription and Real Time 290 
Quantitative PCR were performed as described previously (García-Fernández et al., 2014). 291 
Overexpression and purification of KstR2 292 
Plasmid pET6009 (Table 1) was constructed by cloning into the double-digested pET-29a 293 
plasmid (Table 1) a 615-bp fragment harboring the MSMEG_6009 gene (coding the protein 294 
KstR2), that was amplified by PCR using oligonucleotides pET6009_F and pET6009_R 295 
(Table 1) and total DNA from M. smegmatis as template. The amplified DNA fragment was 296 
digested with HindIII and XhoI and then subcloned into the overexpression vector pET29a 297 
previously digested with the same enzymes and fused at its 3' end-stage to six triplets 298 
encoding a 6His tag, resulting in plasmid pET6009 (Table 1). The strain E. coli BL21 (DE3) 299 
harboring plasmid pET6009 was grown in 500 ml of LB containing kanamycin (50 µg/ml) at 300 
37 ºC up to an A600 of 0.6-0.8, and then expression of kstR2 was induced with 200 µM 301 
isopropyl-1-thio-β-D-galactopyranoside (IPTG), and the strain was kept growing for three 302 
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hours at 37 ºC. Cells were harvested and resuspended in 10 ml of buffer A (20 mM HEPES 303 
pH 7.5, 300 mM KCl, 2 mM ß-mercaptoethanol, 10 mM MgCl2) and lysed using a French 304 
press (Aminco Corp.) operated at a pressure of 20,000 psi. All purification steps were carried 305 
out at 4 °C. Streptomycin sulfate (2%, w/v) was added to the protein extract and vortexed 306 
until complete dissolution to facilitate DNA precipitation. Cell debris was removed by 307 
ultracentrifugation at 50,000 X g for 45 min at 4 °C, and then applied to a HisTrap FF crude 308 
column (GE Healthcare) previously equilibrated with the same buffer A. The column was 309 
then washed with 100 ml of buffer B (buffer A containing 5 mM of imidazole) and 100 ml of 310 
buffer C (buffer A containing 50 mM of imidazole). Protein was eluted with 50 ml of buffer 311 
D (buffer A containing 150 mM of imidazole), and finally the column was washed with 50 ml 312 
of buffer A containing 250 mM of imidazole to ensure complete elution of the protein. The 313 
purity of the collected samples was analyzed by SDS-PAGE (Laemmli, 1970). The fractions 314 
containing KstR2 were concentrated to 4 mg/ml using AmiconUltra concentrating devices 315 
(Millipore) according to the manufacturer’s specifications. After concentration, imidazole was 316 
removed by an overnight dialysis against 20 mM HEPES, pH 7,5, 300 mM KCl, 10 mM 317 
MgCl
 2 and 2 mM ß-mercaptoethanol using a 10,000 MWCO Slide-A-Lyzer dialysis cassette 318 
(Thermo). The concentration of pure KstR2 was calculated with a NanoPhotometerPearl 319 
(Implen, Munich, Germany) using the molar extinction coefficient at 280 nm (30940 M-1 cm-320 
1) calculated on the basis of its amino acid sequence using the ExPASy server 321 
(http://expasy.org/). The purified protein was kept at 4 °C for immediate use or at -20 °C with 322 
10% glycerol for longer periods of time. 323 
Electro-mobility shift assays (EMSA) 324 
Oligonucleotide 6000FP_F was labeled using 2.5 µl of oligonucleotide (2 mM), 1.25 µl of 325 
10x kinase buffer (Biolabs), 3 µl of [γ-32P]ATP (3000 Ci/mmol) (Amersham Pharmacia 326 
15 
 
Biotech) and 10 U of T4 polynucleotide kinase (Biolabs) in a total volume of 10 µl. The 327 
reaction mixture was incubated for 30 min at 37 °C. Once labelled the oligonucleotide of 328 
interest, 6000FP fragment (164 bp) was obtained by PCR using as template 100 ng of M. 329 
smegmatis DNA and oligonucleotides 6000FP_F and 6000FP_R (Table 1) as labeled and 330 
unlabeled oligonucleotides, respectively. We used 10 µl of labeled oligonucleotide (5 pmol), 331 
7.5 µl of 1 µM cold oligonucleotide (7.5 pmol), 4 µl of 2.5 mM dNTPs (0.2 mM final), 5 µl of 332 
10x Taq polymerase buffer, 1 µl of Taq polymerase and 1 µl of template DNA (100 ng/ml) in 333 
a final volume of 50 µl. The amplified product was purified with High Pure PCR System 334 
Product Purification Kit (Roche) and eluted in a final volume of 100 µl.  335 
For titration assays, varying amounts of purified KstR2 were incubated with 1 nM of 336 
labelled probe in binding buffer (20 mM Tris-HCl at pH 8, 150 mM KCl, 10 mM MgCl2, 10% 337 
glycerol, 2 mM ß-mercaptoethanol, and 50 µg ml-1 BSA) in a final volume of 9 µl. For 338 
specific and nonspecific competition reaction mixtures, 10, 100, or 1000 fold excess of 339 
unlabeled probe and 0.5, 1, and 2 µg of unspecific DNA (salmon sperm) were added, 340 
respectively. To test the binding of KstR2 to DNA in the presence of the different inducers, 341 
the compounds were dissolved in methanol and were incubated with KstR2 for 10 min at 342 
room temperature before adding the DNA probe. 343 
The EMSA reaction mixtures were incubated for 20 min at room temperature and 344 
fractionated by electrophoresis on a 5% polyacrylamide gels buffered with 0.5x TBE (45 mM 345 
Tris borate, 1 mM EDTA). The gels were dried onto Whatman 3MM paper and exposed to 346 
Hyperfilm MP (Amersham Biosciences) using amplifying screens (Cronex DuPont Lightning 347 
Plus).  348 
DNase I footprinting assays 349 
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For footprinting experiments the 6000FP (164 bp) DNA fragment was amplified by PCR 350 
using 6000FP_R as cold oligonucleotide and 6000FP_F as labeled oligonucleotide (as 351 
described above). The labeled fragment was purified by using Gene-Clean Turbo (Q-352 
BIOgene). For DNase I footprinting assays, the reaction mixture containing binding buffer, 4 353 
nM of 6000FP probe, BSA (50 µg/ml), and various dilutions of KstR2 purified protein were 354 
incubated for 20 min at room temperature in a final volume of 15 µl. Then we added 3 µl of 355 
DNase I (1 µg/ml (Amersham Biosciences) in 10 mM Tris-HCl pH 7.5, 10 mM MgCl2, 10 356 
mM CaCl2 and 125 mM KCl and the mixture was incubated at 37 °C for 23 s. The reaction 357 
was stopped by adding 10 µl of phenol, vortexing and adding immediately after 180 µl of 358 
DNase STOP solution (2 M sodium acetate, 12.5 mM EDTA, 250 µg/ml salmon sperm DNA) 359 
and 0.3 µg/ml of glycogen. DNA fragments were precipitated with 3 volumes of absolute 360 
ethanol, washed with 70% ethanol, pelleted, dried and kept at -20 ºC until use. The different 361 
samples were directly resuspended in 98% (v/v) formamide-loading gel buffer (10 mM Tris-362 
HCl, pH 8.0, 20 mM EDTA, pH 8.0, 0.05% (w/v) bromophenol blue, 0.05% (w/v) xylene 363 
cyanol), denatured at 95 °C for 3 min and analyzed on a denaturing 6% polyacrylamide-8 M 364 
urea gel. Protected bands were identified by comparison with the migration of the same 365 
fragment treated for the A+G sequencing reaction (Maxam and Gilbert, 1977). The gels were 366 
dried onto Whatman 3MM paper and exposed to Hyperfilm MP (Amersham Pharmacia 367 
Biotech). 368 
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Table 1. Bacterial strains, plasmids and primers used in this study. 492 
 493 
Strains and 
plasmids Relevant genotype and characteristic(s) 
Reference 
/ source 
Strains   
E. coli 
BL21(DE3) 
F-, ompT, hsdSB(rB-mB-), gal, dcm, λDE3 (harbouring gene 1 of the RNA 
polymerase from the phage T7 under the PlacUV5 promoter) 
Sambrook 
and 
Russell, 
2001 
M. smegmatis 
mc2155 ept-1 , mc²6 mutant efficient for electroporation 
Snapper et 
al., 1990 
M. smegmatis 
kstR2 mutant 
(∆kstR2) 
mc2155 strain containing a 505-bp pair deletion in the MSMEG_6009 gene 
encoding KstR2 
Kendall et 
al., 2010 
Plasmids   
pET-29a (+) Cloning and expression vector, Kmr, oriColE1, T7 promoter Novagen 
pET6009 pET29 containing MSMEG_6009 gene encoding KstR2 This study 
Primers   
pET6009_F GCAAGCTTTGACCTAAGGAGGTGAATAATGGCGCCGGATACG  This study 
pET6009_R GGCTCGAGGGCATGTTTATCTCCTTGTG  This study 
6000FP_F GGTGACCGAGACGATGCCCG This study 
6000FP_R CCACCTTGCCGGTCAAACC  This study 
2758int_F CTTGAGGTGACCGACGATCTC This study 
2758int_R GCATCAGCTTCTTCTTCCTCG This study 
5994int_F TCAACGGAACCAAAATCGGTG This study 
5994int_R CAGTGCGAGTTGGTTGACC This study 
6000int_F TGCCGTACGAGTTCCACAGC This study 
6000int_R CCTGGTTCTGCATGACCGC This study 
 494 
495 
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LEGENDS TO THE FIGURES 496 
 497 
Fig. 1. KstR2 regulon of M. smegmatis. A) Genes identified as being part of the KstR2 498 
regulon are in black. The symbols D1* (divergon), D2* (divergon) and P* indicate the 499 
location of the KstR2-binding motifs. Numbers identify the genes according to annotation of 500 
M. smegmatis mc2 155. B) Sequences of the promoter regions containing the KstR2 operators 501 
are shown in boxes. The start codons of the genes are underlined. The length of the regions 502 
(bp) within the two start codons is indicated in parenthesis. The genes are indicated by 503 
numbers and black arrows showing the direction of transcription. The putative -35 and -10 504 
(TGn extended) promoter sequences are indicated by black and red (complementary strand) 505 
arrows. 506 
 507 
Fig. 2. Identification of the KstR2 binding site to the divergon P6000-P6001 by Dnase I 508 
footprinting assay. The lanes marked as AG show the sequencing reaction of the 6000FP 509 
probe by the method of Maxam and Gilbert. Lane 1, 2 and 3, reaction without KstR2. Lanes 510 
4-8, reactions with increasing concentrations of KstR2, i.e., 25, 50, 250, 500 and 1000 nM, 511 
respectively. On the right side of the figure is shown the sequence of the region protected by 512 
KstR2. The palindromic sequence of the KstR2 motif is shown inside the boxes.  513 
 514 
Fig. 3. Lower pathway of cholesterol catabolism. Initial steps of the lower cholesterol 515 
catabolic pathway are shown with intermediates relevant to the current studies. Gross black 516 
arrows represent multiple enzymatic steps. Dashed arrows represent improbable steps. Double 517 
arrow indicates a pH dependent spontaneous reversible reaction. The names of the enzymes 518 
are indicated. FadD3 and IpdBD are in discussion as alternative CoA ligases. ORF? means 519 
that the enzyme is unknown. 520 
24 
 
 521 
Fig. 4. Gene expressions in the presence of cholesterol or HIL compared to the basal 522 
expression in the presence of glycerol. RT-QPCR was used to measure the relative 523 
expressions of MSMEG_6000 and MSMEG_5994 selected as representative inducible genes 524 
of the kstR2 (lower pathway) and kstR (upper pathway) regulons, respectively. M. smegmatis 525 
was grown on 18 mM glycerol (control), 1.8 mM cholesterol or 4 mM HIL. 526 
527 
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Figure 1 528 
 529 
 530 
531 
CGCCGGCTTCTGGCATATCGGTCACTGTGCTAGCGTACCAAGCAAGTGCTTGCTTAGGTAGCCGACCAG
GAACGATCAGGAATCCGATGACGATCACATCCACCACCGTCGAACCGGGCATCGTCTCGGTCACCGTGA
6001
6000
Divergon region D1 (60 bp)
CTGGGCGTATCCGGCGCCATTGACCCAGCATACCAACCAAGCACTTGCTAGGTCACGTCGGGCGGGAGA
TGCCACCACGCGCCGAGATTGCATCCAGGGACAAAAAATCGCCGGGACGTGTCCCTCAGTGCAGTCTCG
Promoter region P (303 bp)
6009
Divergon region D2 (104 bp)
ACTCCTGGACCTCTATCACCCTTGTAGGCTAACCTACCAAGCACTTGCTTTGTTAGAGGAGCACCTGATGA
CGAGCGCCGTTGGTCACGCGTGCAGCGACCGGGGGGTCAGAACCGTTCCAGCGGTGCTGGACCGGATC
6012
6013
A
*D1 *P *D2
6000
echA20
6001
kstR2
6009
fadE30
6012
fadD3
6013
ipdA
6002
ipdB
6003
fdxB
6005
fadA6
6008
fadE31
6014
fadE32
6015
fadE33
6016
aspB
6017
B
5999 6004 60116006 6007 6010
-35 -10 ext
-10 ext -35
-10 ext -35
-35 -10 ext
-10 ext -35
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Figure 2 532 
 533 
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Figure 3 537 
 538 
 539 
 540 
541 
Central
metabolism
CHOLESTEROL
FadD3
or
IpdAB
HIP HIL5OH-HIP
HIP-CoA 5OH-HIP-CoA
Central
metabolism
FadE30
HsaEFG
HsaD
Ppi 
AMP
ATP 
CoASH
Ppi 
AMP
ATP 
CoASH FadD3
or
IpdAB
ORF?
ORF?
pH dep.
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Figure 4 542 
 543 
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Supplementary Material 546 
 547 
Fig. S1. EMSA using purified KstR2 with 6000FP probe. A) Lane 1, reaction without KstR2. 548 
Lanes 2-9, reactions with increasing concentrations of KstR2, i.e., 15, 30, 45, 60, 75, 90, 105 549 
and 120 nM, respectively. B) Lane 1, reaction without KstR2. Lanes 2-8, reactions with 150 550 
nM of KstR2; Lanes 3-5, reactions with increasing concentrations of unlabeled 6000FP probe, 551 
i.e., 10, 100, and 1000 nM, respectively; Lanes 6-8, reactions with increasing concentrations 552 
of salmon DNA, i.e., 0.5, 1 and 2 µg, respectively. The locations of the probe and the 553 
complex probe/protein are indicated by arrows. 554 
 555 
Fig. S2. 3D-model and CD spectrum of KstR2. A) Representation of the 3D-model of KstR2 556 
generated with the Pymol Molecular Graphics System (http://www.pymol.org). Residues 557 
forming the tunnel-shaped hydrophobic pocket are shown as sticks. B) CD spectrum of the 558 
unliganded KstR2. 559 
 560 
Fig. S3. Growth curves of M. smegmatis strains. The wild type and the KstR2 deletion mutant 561 
(∆kstR2) were cultured in minimal medium containing glycerol (1 mM) plus HIL (4 mM), 562 
cholesterol (1.8 mM) or HIL (4 mM) as the sole carbon and energy sources. 563 
 564 
565 
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Figure S1 566 
 567 
 568 
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Figure S2 570 
 571 
 572 
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Figure S3 574 
 575 
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